613
Participants
Start Date
October 27, 2023
Primary Completion Date
August 21, 2028
Study Completion Date
July 18, 2030
Ianalumab (VAY736)
Ianalumab 300 mg / 2 mL, PFS or AI, monthly or every 3 months, solution for injection for subcutaneous use
Placebo
Placebo 0 mg/2 mL PFS or AI, once monthly between doses of Ianalumab 3 monthly , solution for injection for subcutaneous Use
Novartis Investigative Site, Sofia
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Quilmes
Novartis Investigative Site, Stockerau
Novartis Investigative Site, Leuven
Novartis Investigative Site, Eger
Novartis Investigative Site, San Miguel de Tucumán
Novartis Investigative Site, Debrecen
Novartis Investigative Site, Maroochydore
Novartis Investigative Site, Woodville South
Novartis Investigative Site, Gyula
Novartis Investigative Site, Szeged
Novartis Investigative Site, Concepción
Novartis Investigative Site, Hobart
Novartis Investigative Site, Panorama
Novartis Investigative Site, Stellenbosch
Novartis Investigative Site, Burgas
Novartis Investigative Site, Székesfehérvár
Novartis Investigative Site, Graz
Novartis Investigative Site, Quetzaltenango
Winthrop University Hospital, Mineola
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
St Lawrence Health System, Potsdam
Novartis Investigative Site, Córdoba
Novartis Investigative Site, A Coruña
Altoona Center for Clin Res, Duncansville
Novartis Investigative Site, Milan
Novartis Investigative Site, Dijon
The John Hopkins Jerome L Greene Sjogren, Baltimore
Novartis Investigative Site, Madrid
On Site Clinical Solutions Llc, Charlotte
Arthritis and Osteoporosis, Charlotte
Novartis Investigative Site, Brest
North GA Rheumatology Group PC, Suwanee
Novartis Investigative Site, Hanover
Augusta University Georgia, Augusta
GNP Research, Cooper City
West Broward Rheumatology Associates Inc, Tamarac
Bay Area Arthritis And Osteoporosis, Brandon
Sarasota Arthritis Res Ctr, Sarasota
Novartis Investigative Site, Vigo
Shelby Research LLC, Memphis
West Tennessee Research Institute, Jackson
Novartis Investigative Site, Santander
Novartis Investigative Site, Taichung
Novartis Investigative Site, Kocaeli
Novartis Investigative Site, Saint-Etienne
Novartis Investigative Site, Herne
Novartis Investigative Site, Guadalajara
STAT Research Inc, Dayton
Novartis Investigative Site, Valencia
Novartis Investigative Site, Bilbao
Novartis Investigative Site, Angers
Novartis Investigative Site, Wroclaw
Novartis Investigative Site, Cologne
Novartis Investigative Site, Lille
Novartis Investigative Site, Ancona
Clin Invest Specialists Inc, Orland Park
Novartis Investigative Site, Gwangju
Novartis Investigative Site, Brno
University of Kansas Hospital, Kansas City
Novartis Investigative Site, Strasbourg
Novartis Investigative Site, Ludwigshafen
Ochsner Health System, Baton Rouge
Novartis Investigative Site, Le Mans
RAO Research LLS, Oklahoma City
Novartis Investigative Site, Paris
Novartis Investigative Site, Paris
Precision Comprehensive Research, Colleyville
Baylor College Of Medicine, Houston
Prolato Clinical Research Center, Houston
Advanced Rheumatology of Houston, Spring
Houston Rheumatology & Arthrit, Katy
First Outpatient Research Unit, San Antonio
Novartis Investigative Site, Freiburg im Breisgau
Novartis Investigative Site, Napoli
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Kaohsiung City
Novartis Investigative Site, Kaohsiung City
Novartis Investigative Site, Salerno
Arthritis Osteoporosis Assoc of NM, Las Cruces
Advanced Medical Research, La Palma
Novartis Investigative Site, Erlangen
Medvin Clinical Research, Van Nuys
Providence Medical Foundation, Fullerton
Novartis Investigative Site, Le Kremlin-Bicêtre
Novartis Investigative Site, Mérida
Novartis Investigative Site, Würzburg
Arthritis Northwest PLLC, Spokane
Novartis Investigative Site, Beijing
Novartis Investigative Site, Beijing
Novartis Investigative Site, Beijing
Novartis Investigative Site, Shenyang
Novartis Investigative Site, New Delhi
Novartis Investigative Site, Bogotá
Novartis Investigative Site, Changchun
Novartis Investigative Site, Shanghai
Novartis Investigative Site, Nanjing
Novartis Investigative Site, Hefei
Novartis Investigative Site, Linyi
Novartis Investigative Site, Tianjin
Novartis Investigative Site, Nanchang
Novartis Investigative Site, Pingxiang
Novartis Investigative Site, Ahmedabad
Novartis Investigative Site, Ahmedabad
Novartis Investigative Site, Cluj-Napoca
Novartis Investigative Site, Chongqing
Novartis Investigative Site, Taichung
Novartis Investigative Site, Wuhan
Novartis Investigative Site, Xinxiang
Novartis Investigative Site, Brasov
Novartis Investigative Site, Guangzhou
Novartis Investigative Site, Shenzhen
Novartis Investigative Site, Chengdu
Novartis Investigative Site, Shanxi
Novartis Investigative Site, Yinchuan
Novartis Investigative Site, Kfar Saba
Novartis Investigative Site, Braga
Novartis Investigative Site, Valdivia
Novartis Investigative Site, Ramat Gan
Novartis Investigative Site, Santiago
Novartis Investigative Site, Santiago
Novartis Investigative Site, Santiago
Tufts School of Dental Medicine, Boston
Novartis Investigative Site, CABA
Novartis Investigative Site, Ciudad Autonoma de Bs As
Novartis Investigative Site, Ciudad Autonoma de Bs As
Novartis Investigative Site, Vitória
Novartis Investigative Site, Salvador
Novartis Investigative Site, Juiz de Fora
Novartis Investigative Site, Ribeirão Preto
Novartis Investigative Site, São Paulo
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Sydney
Novartis Investigative Site, Rimouski
Novartis Investigative Site, Sherbrooke
Novartis Investigative Site, Trois-Rivières
Novartis Investigative Site, Baotou
Novartis Investigative Site, Taiyuan
Novartis Investigative Site, Taiyuan
Novartis Investigative Site, Medellín
Novartis Investigative Site, Barranquilla
Novartis Investigative Site, Bucaramanga
Novartis Investigative Site, Uherské Hradiště
Novartis Investigative Site, Dresden
Novartis Investigative Site, Athens
Novartis Investigative Site, Athens
Novartis Investigative Site, Guatemala City
Novartis Investigative Site, Guatemala City
Novartis Investigative Site, Guatemala City
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Kitakyushu
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Yokohama
Novartis Investigative Site, Kuwana
Novartis Investigative Site, Sasebo
Novartis Investigative Site, Kurashiki
Novartis Investigative Site, Bunkyo Ku
Novartis Investigative Site, Chuo Ku
Novartis Investigative Site, Itabashi-ku
Novartis Investigative Site, Meguro-ku
Novartis Investigative Site, Shinjuku-ku
Novartis Investigative Site, Vilnius
Novartis Investigative Site, Mexico City
Novartis Investigative Site, Culiacán
Novartis Investigative Site, México
Novartis Investigative Site, Poznan
Novartis Investigative Site, Krakow
Novartis Investigative Site, Wroclaw
Novartis Investigative Site, Wroclaw
Novartis Investigative Site, Bydgoszcz
Novartis Investigative Site, Krakow
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Guarda
Novartis Investigative Site, Lisbon
Novartis Investigative Site, Lisbon
Novartis Investigative Site, Lisbon
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Singapore
Novartis Investigative Site, Košice
Novartis Investigative Site, Zvolen
Novartis Investigative Site, Seoul
Novartis Investigative Site, Sabadell
Novartis Investigative Site, Badalona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Stockholm
Novartis Investigative Site, Ankara
Novartis Investigative Site, Ankara
Novartis Investigative Site, Ankara
Novartis Investigative Site, Leeds
Novartis Investigative Site, Liverpool
Novartis Investigative Site, Newcastle upon Tyne
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY